Effects of red yeast rice prescription (LipoCol Forte) on adverse outcomes of surgery

T. L. Chen, C. C. Yeh, C. S. Lin, C. C. Shih, C. C. Liao

研究成果: 雜誌貢獻文章

摘要

Background The influence of red yeast rice (RYR) on perioperative outcome remains unknown. Aim We aimed to compare the complications and mortality after surgery between patients treated with and without RYR prescription. Design In this surgical cohort study of 3.6 million surgical patients who underwent major inpatient surgeries, 2581 patients who used RYR prescription pre-operatively were compared with 25 810 non-RYR patients selected by matching for age and sex. Methods Patients' demographics and medical conditions were collected from the claims data of the National Health Insurance in Taiwan. Complications and mortality after major surgeries in association with RYR prescription were investigated by calculating adjusted odds ratios (ORs) and 95% confidence intervals (CIs) by multiple logistic regression. Results Compared with patients without RYR prescription, patients prescribed RYR had lower risks of post-operative bleeding (OR 0.36, 95% CI 0.15-0.89), pneumonia (OR 0.54, 95% CI 0.36-0.83), stroke (OR 0.66, 95% CI 0.47-0.92) and 30-day in-hospital mortality (OR 0.37, 95% CI 0.15-0.92). Decreased risk of intensive care (OR 0.64, 95% CI 0.54-0.77), shorter length of hospital stay (P < 0.001) and lower medical expenditures (P = 0.0008) during the index surgical admission were also noted for patients with RYR prescription compared to those for patients without RYR prescription. Conclusions This study showed a potentially positive effect of RYR on outcomes after major surgeries. However, patient non-compliance for taking medication should be noted. Our findings require future prospective studies to validate RYR prescription for improving perioperative outcomes.
原文英語
頁(從 - 到)253-259
頁數7
期刊QJM
112
發行號4
DOIs
出版狀態已發佈 - 四月 1 2019

指紋

Prescriptions
Odds Ratio
Confidence Intervals
Length of Stay
red yeast rice
Mortality
National Health Programs
Critical Care
Patient Compliance
Health Expenditures
Hospital Mortality
Taiwan
Inpatients
Pneumonia
Cohort Studies
Yeasts
Logistic Models
Stroke
Demography
Prospective Studies

ASJC Scopus subject areas

  • Medicine(all)

引用此文

Effects of red yeast rice prescription (LipoCol Forte) on adverse outcomes of surgery. / Chen, T. L.; Yeh, C. C.; Lin, C. S.; Shih, C. C.; Liao, C. C.

於: QJM, 卷 112, 編號 4, 01.04.2019, p. 253-259.

研究成果: 雜誌貢獻文章

@article{a292244a12e34c14bf955272562a4dea,
title = "Effects of red yeast rice prescription (LipoCol Forte) on adverse outcomes of surgery",
abstract = "Background The influence of red yeast rice (RYR) on perioperative outcome remains unknown. Aim We aimed to compare the complications and mortality after surgery between patients treated with and without RYR prescription. Design In this surgical cohort study of 3.6 million surgical patients who underwent major inpatient surgeries, 2581 patients who used RYR prescription pre-operatively were compared with 25 810 non-RYR patients selected by matching for age and sex. Methods Patients' demographics and medical conditions were collected from the claims data of the National Health Insurance in Taiwan. Complications and mortality after major surgeries in association with RYR prescription were investigated by calculating adjusted odds ratios (ORs) and 95{\%} confidence intervals (CIs) by multiple logistic regression. Results Compared with patients without RYR prescription, patients prescribed RYR had lower risks of post-operative bleeding (OR 0.36, 95{\%} CI 0.15-0.89), pneumonia (OR 0.54, 95{\%} CI 0.36-0.83), stroke (OR 0.66, 95{\%} CI 0.47-0.92) and 30-day in-hospital mortality (OR 0.37, 95{\%} CI 0.15-0.92). Decreased risk of intensive care (OR 0.64, 95{\%} CI 0.54-0.77), shorter length of hospital stay (P < 0.001) and lower medical expenditures (P = 0.0008) during the index surgical admission were also noted for patients with RYR prescription compared to those for patients without RYR prescription. Conclusions This study showed a potentially positive effect of RYR on outcomes after major surgeries. However, patient non-compliance for taking medication should be noted. Our findings require future prospective studies to validate RYR prescription for improving perioperative outcomes.",
author = "Chen, {T. L.} and Yeh, {C. C.} and Lin, {C. S.} and Shih, {C. C.} and Liao, {C. C.}",
year = "2019",
month = "4",
day = "1",
doi = "10.1093/qjmed/hcy278",
language = "English",
volume = "112",
pages = "253--259",
journal = "QJM - Monthly Journal of the Association of Physicians",
issn = "1460-2725",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Effects of red yeast rice prescription (LipoCol Forte) on adverse outcomes of surgery

AU - Chen, T. L.

AU - Yeh, C. C.

AU - Lin, C. S.

AU - Shih, C. C.

AU - Liao, C. C.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Background The influence of red yeast rice (RYR) on perioperative outcome remains unknown. Aim We aimed to compare the complications and mortality after surgery between patients treated with and without RYR prescription. Design In this surgical cohort study of 3.6 million surgical patients who underwent major inpatient surgeries, 2581 patients who used RYR prescription pre-operatively were compared with 25 810 non-RYR patients selected by matching for age and sex. Methods Patients' demographics and medical conditions were collected from the claims data of the National Health Insurance in Taiwan. Complications and mortality after major surgeries in association with RYR prescription were investigated by calculating adjusted odds ratios (ORs) and 95% confidence intervals (CIs) by multiple logistic regression. Results Compared with patients without RYR prescription, patients prescribed RYR had lower risks of post-operative bleeding (OR 0.36, 95% CI 0.15-0.89), pneumonia (OR 0.54, 95% CI 0.36-0.83), stroke (OR 0.66, 95% CI 0.47-0.92) and 30-day in-hospital mortality (OR 0.37, 95% CI 0.15-0.92). Decreased risk of intensive care (OR 0.64, 95% CI 0.54-0.77), shorter length of hospital stay (P < 0.001) and lower medical expenditures (P = 0.0008) during the index surgical admission were also noted for patients with RYR prescription compared to those for patients without RYR prescription. Conclusions This study showed a potentially positive effect of RYR on outcomes after major surgeries. However, patient non-compliance for taking medication should be noted. Our findings require future prospective studies to validate RYR prescription for improving perioperative outcomes.

AB - Background The influence of red yeast rice (RYR) on perioperative outcome remains unknown. Aim We aimed to compare the complications and mortality after surgery between patients treated with and without RYR prescription. Design In this surgical cohort study of 3.6 million surgical patients who underwent major inpatient surgeries, 2581 patients who used RYR prescription pre-operatively were compared with 25 810 non-RYR patients selected by matching for age and sex. Methods Patients' demographics and medical conditions were collected from the claims data of the National Health Insurance in Taiwan. Complications and mortality after major surgeries in association with RYR prescription were investigated by calculating adjusted odds ratios (ORs) and 95% confidence intervals (CIs) by multiple logistic regression. Results Compared with patients without RYR prescription, patients prescribed RYR had lower risks of post-operative bleeding (OR 0.36, 95% CI 0.15-0.89), pneumonia (OR 0.54, 95% CI 0.36-0.83), stroke (OR 0.66, 95% CI 0.47-0.92) and 30-day in-hospital mortality (OR 0.37, 95% CI 0.15-0.92). Decreased risk of intensive care (OR 0.64, 95% CI 0.54-0.77), shorter length of hospital stay (P < 0.001) and lower medical expenditures (P = 0.0008) during the index surgical admission were also noted for patients with RYR prescription compared to those for patients without RYR prescription. Conclusions This study showed a potentially positive effect of RYR on outcomes after major surgeries. However, patient non-compliance for taking medication should be noted. Our findings require future prospective studies to validate RYR prescription for improving perioperative outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85064110924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064110924&partnerID=8YFLogxK

U2 - 10.1093/qjmed/hcy278

DO - 10.1093/qjmed/hcy278

M3 - Article

VL - 112

SP - 253

EP - 259

JO - QJM - Monthly Journal of the Association of Physicians

JF - QJM - Monthly Journal of the Association of Physicians

SN - 1460-2725

IS - 4

ER -